Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy
Gregory Y.H. Lip; Lars H. Rasmussen; S. Bertil Olsson; Sofia Zetterstrand; Christina Stahre; Anders Bylock; Maria Aunes-Jansson; Ulf Eriksson; Karin Wåhlander
- 作者Gregory Y.H. Lip; Lars H. Rasmussen; S. Bertil Olsson; Sofia Zetterstrand; Christina Stahre; Anders Bylock; Maria Aunes-Jansson; Ulf Eriksson; Karin Wåhlander
- 卷第127卷
- 期第2期
- 印刷ISSN0049-3848
- 文件大小658.73KB
- 发表时间2011
- DOI10.1016/j.thromres.2010.11.012